Clinical Trials Sponsored by Kite Systems
Total 3638 results
-
Kite SystemsRambam Health Care CampusUnknown
-
Stanford UniversityKite PharmaRecruitingNon-Hodgkin Lymphoma | Large B-cell LymphomaUnited States
-
Stanford UniversityKite PharmaRecruitingLymphoblastic LeukemiaUnited States
-
PEMF Systems, Inc.Henry Ford Health SystemTerminatedVenous Stasis UlcersUnited States
-
Kite, A Gilead CompanyRecruitingRelapsed/Refractory Large B-cell LymphomaUnited States, Australia, Canada
-
Kite, A Gilead CompanyRecruitingHigh-risk Large B-cell Lymphoma (LBCL)United States, Austria, Spain, Italy, Australia, Germany, Netherlands, Canada, Portugal, United Kingdom, France
-
Kite, A Gilead CompanyAvailableAcute Lymphoblastic Leukemia | Mantle Cell LymphomaUnited States
-
Kite, A Gilead CompanyAvailableFollicular Lymphoma | Large B-cell LymphomaUnited States, Japan
-
Kite, A Gilead CompanyCompletedRelapsed/Refractory Mantle Cell LymphomaUnited States, Netherlands, Germany, France
-
Kite, A Gilead CompanyCompletedRelapsed/Refractory B-precursor Acute Lymphoblastic LeukemiaUnited States, France, Germany, Netherlands, Canada
-
Kite, A Gilead CompanyCompletedB-cell LymphomaUnited States, Australia, France
-
Kite, A Gilead CompanyTerminatedRelapsed/Refractory Multiple MyelomaUnited States
-
Kite, A Gilead CompanyRecruitingRelapsed/Refractory Mantle Cell Lymphoma | Relapsed/Refractory B-precursor Acute Lymphoblastic LeukemiaJapan
-
Kite, A Gilead CompanyRecruitingRelapsed/Refractory Waldenstrom Macroglobulinemia | Relapsed/Refractory Richter Transformation | Relapsed/Refractory Burkitt Lymphoma | Relapsed/Refractory Hairy Cell LeukemiaUnited States, Spain, Germany, Italy, France, Netherlands, Switzerland, Austria
-
Kite, A Gilead CompanyRecruitingRelapsed/Refractory Follicular LymphomaUnited States, Spain, United Kingdom, Italy, France, Japan, Germany
-
Kite, A Gilead CompanyActive, not recruitingRelapsed or Refractory Large B-cell LymphomaUnited States
-
Kite, A Gilead CompanyActive, not recruitingRelapsed/Refractory Diffuse Large B-Cell Lymphoma (DLBCL)United States, Spain, United Kingdom, Canada, Netherlands, Germany, France, Sweden, Israel, Switzerland, Belgium, Australia, Austria, Italy
-
Kite, A Gilead CompanyCompletedRefractory Large B-cell LymphomaUnited States
-
Kite, A Gilead CompanyTerminatedRelapsed/Refractory Chronic Lymphocytic Leukemia and Relapsed/Refractory Small Lymphocytic LymphomaUnited States, Italy
-
Kite, A Gilead CompanyApproved for marketingRelapsed/Refractory Diffuse Large B Cell Lymphoma | Relapsed/Refractory Primary Mediastinal B Cell Lymphoma | Relapsed/Refractory Transformed Follicular Lymphoma | Relapsed/Refractory High-Grade B-Cell LymphomaUnited States
-
Kite, A Gilead CompanyCompletedRelapsed Diffuse Large B-Cell Lymphoma | Refractory Diffuse Large B Cell Lymphoma (DLBCL) | Transformed Follicular Lymphoma (TFL) | Primary Mediastinal B-cell Lymphoma (PMBCL) | High Grade B-cell Lymphoma (HGBCL)United States, Netherlands, Canada, France, Germany, Israel
-
Kite, A Gilead CompanyTerminated
-
Kite, A Gilead CompanyRecruitingRelapsed and/or Refractory B-cell LymphomaUnited States, Netherlands, United Kingdom, Germany
-
Kite, A Gilead CompanyRecruitingRelapsed/Refractory B-precursor Acute Lymphoblastic Leukemia | Relapsed/Refractory B-Cell Non-Hodgkin LymphomaSpain, United States, Canada, Belgium, Poland, Czechia, Italy, France, Germany, Netherlands, Sweden
-
Kite, A Gilead CompanyEnrolling by invitationSolid and Hematological MalignanciesUnited States, Netherlands, Japan, Australia, France, Israel, Germany, Canada, United Kingdom
-
Kite, A Gilead CompanyActive, not recruitingAcute Myeloid LeukemiaUnited States, France
-
Kite, A Gilead CompanyActive, not recruitingFollicular Lymphoma | Marginal Zone Lymphoma | Indolent Non-Hodgkin LymphomaUnited States, France
-
Kite, A Gilead CompanyTerminatedMultiple Myeloma | Ovarian Cancer | Fallopian Tube Cancer | Non-Small Cell Lung Cancer | Triple Negative Breast Cancer | Pancreatic Ductal AdenocarcinomaUnited States
-
Kite, A Gilead CompanyActive, not recruitingRelapsed/Refractory Mantle Cell LymphomaUnited States, France, Spain, United Kingdom, Netherlands, Germany
-
Kite, A Gilead CompanyApproved for marketingRelapse/Refractory Mantle Cell LymphomaUnited States
-
Can-Fite BioPharmaNot yet recruitingPancreatic Cancer | Pancreatic AdenocarcinomaIsrael
-
Can-Fite BioPharmaRecruitingNASH - Nonalcoholic SteatohepatitisIsrael, Bosnia and Herzegovina, Bulgaria, Moldova, Republic of, Romania, Serbia
-
Can-Fite BioPharmaCompletedHepatocellular CarcinomaUnited States, Israel, Bulgaria, Romania, Serbia
-
Can-Fite BioPharmaCompletedOcular Hypertension | GlaucomaIsrael, Bulgaria
-
Can-Fite BioPharmaCompletedKeratoconjunctivitis SiccaIsrael
-
Can-Fite BioPharmaTerminatedRheumatoid ArthritisBosnia and Herzegovina, Canada, Israel, Moldova, Republic of, Poland, Romania, Serbia
-
Can-Fite BioPharmaCompletedRheumatoid ArthritisIsrael, Czechia, Bulgaria, Poland, Serbia, Ukraine
-
University of PennsylvaniaKite, A Gilead CompanyRecruiting
-
Kite, A Gilead CompanyPfizerTerminatedRelapsed/Refractory Large B-cell LymphomaUnited States
-
Can-Fite BioPharmaCompletedRheumatoid ArthritisUnited States, Bulgaria, Israel, Poland, Romania, Serbia, Ukraine
-
Can-Fite BioPharmaCompleted
-
Can-Fite BioPharmaCompletedPlaque PsoriasisIsrael, Serbia, Romania, Croatia, Bosnia and Herzegovina, Bulgaria, Canada, Moldova, Republic of, Poland
-
Can-Fite BioPharmaCompletedRheumatoid ArthritisBulgaria, Israel
-
Can-Fite BioPharmaCompletedHepatocellular CarcinomaIsrael
-
Can-Fite BioPharmaCompletedPlaque PsoriasisIsrael, United States, Bulgaria, Romania
-
Can-Fite BioPharmaCompletedNon-alcoholic Steatohepatitis (NASH)Israel
-
Can-Fite BioPharmaWithdrawnUveitis, Posterior | Uveitis, IntermediateIsrael
-
Can-Fite BioPharmaCompletedChronic Hepatitis CIsrael
-
Can-Fite BioPharmaRecruitingHepatocellular Carcinoma | CirrhosisUnited States, Bosnia and Herzegovina, Bulgaria, Israel, Moldova, Republic of, Poland, Romania, Serbia, Slovakia
-
Can-Fite BioPharmaCompleted